Designed and built with care, filled with creative elements

Learn about 21 CFR Part 11 (Electronic Records/Electronic Signatures) guidance.

Follow Us

Call Toll Free +1(888) 881 2588

support@federalcomply.com

  • No products in the cart.
a
  /  FDA Regulatory Compliance  /  Learn about 21 CFR Part 11 (Electronic Records/Electronic Signatures) guidance.

Learn about 21 CFR Part 11 (Electronic Records/Electronic Signatures) guidance.

$99

About this course

Watch RECORDED Session for Just $99

Recorded On: April 02, 2019

Training Duration: 90 Minutes

Access any day, anytime, unlimited times as per your convenience*


FDA requires that all computer systems used to produce, manage and report on “GxP” (GMP, GLC, GCP) related products be validated and maintained in accordance with specific rules.  This webinar will help you understand the FDA’s current thinking on computer systems that are validated and subject to inspection and audit.

As a “GxP” system, following Good Manufacturing, Laboratory and Clinical Practices, the computer system must be validated in accordance with FDA requirements.  If electronic records and/or electronic signatures (ER/ES) are incorporated into the system, FDA’s CFR Part 11 guidance on ER/ES must be followed.

This webinar will focus on the key areas that are most important, including security and data integrity.  Implementing and following the System Development Life Cycle (SDLC) methodology is the best approach for computer system validation and maintaining data integrity.  The life cycle approach takes all aspects of validation into account throughout the life of the system and the data that it houses.  The data is a key asset for any FDA-regulated company and must be protected through its entire retention period.

 

Session Highlights:

  1. Manufacturing, Testing, Packaging and Distribution companies in the following industries that are regulated by FDA are required to follow GxPs:
  • Pharmaceutical
  • Medical Device
  • Biologicals
  • Tobacco (based on the Tobacco Control Act of 2009)
  • E-Liquid/Vapor (based on the “Deeming” Act of 2016)
  • E-Cigarette (based on the “Deeming” Act of 2016)
  • Cigar (based on the “Deeming” Act of 2016)
  • Third-Party companies that support those in the above industries, including Contract Research Organizations (CROs)
  • Colleges and Universities offering programs of study in Clinical Trial Management and regulatory

2. Learn about Computer System Validation (CSV) and the System Development Life Cycle (SDLC) Methodology

  • Understand “GxP” Systems
  • Understand 21 CFR Part 11, Electronic Records/Electronic Signatures (ER/ES)
  • Learn how Data Archival plays a key role in ensuring security, integrity and compliance
  • Learn how to develop a solid Validation Strategy that will take into account the system risk assessment and system categorization (GAMP V) processes
  • Learn about recent FDA findings for companies in regulated industries
  • Learn about recent trends in technology that need to be addressed in the CSV approach

 

Why should you attend:

FDA requires that all computer systems that handle data regulated by the Agency to be validated in accordance with their guidance on computerized systems.  This guidance was first issued in 1983, and the main points of focus remain consistent today, despite the number of years that have passed and the technology changes that have taken place.

The guidance was revisited for its application to the medical device industry, as the first issuance addressed pharmaceuticals.  In 1997, 21 CFR Part 11 was issued to address electronic records and signatures, as many laboratories and other FDA-regulated organizations began seeking ways to move into a paperless environment.  This guidance has been modified over the years to make it more palatable to industry, and this includes discretionary enforcement measures.  The intent was to avoid creating a huge regulatory compliance cost to industry that was initially preventing companies from embracing the technology.

This session will provide some insight into current trends in compliance and enforcement.  Some are based on technology changes and these will continue to have an impact as new innovations come into use in the industry.

 

Who Should Attend:

  • Information Technology Analysts
  • QC/QA Managers
  • QC/QA Analysts
  • Clinical Data Managers
  • Clinical Data Scientists
  • Analytical Chemists
  • Compliance Managers
  • Laboratory Managers
  • Automation Analysts
  • Manufacturing Managers
  • Manufacturing Supervisors
  • Supply Chain Specialists
  • Computer System Validation Specialists
  • GMP Training Specialists
  • Business Stakeholders responsible for computer system validation planning, execution, reporting, compliance, maintenance and audit
  • Consultants working in the life sciences industry who are involved in computer system implementation, validation and compliance
  • Auditors engaged in the internal inspection of labeling records and practices.

 

In this Recorded Sessionyou can listen to Q&A which includes direct answer from our expert speaker.

*Instruction kit to access the session will be emailed within 6 hours.

Reviews

0
0 Ratings

5 Stars

0

4 Stars

0

3 Stars

0

2 Stars

0

1 Stars

0

User registration

Reset password